Channelopathy - PDFSEARCH.IO - Document Search Engine

Channelopathy
Results: 689

#	Item
231	Long QT Syndrome Syndrome— —Cardiovascular disease 3 Fact Sheet 55 Important points Many forms of cardiovascular disease are caused by interruptions to the heart’s normal contract-relax cycle and cause abnormally Add to Reading List Source URL: www.genetics.edu.au Language: English - Date: 2014-09-07 20:44:04 Biology Syndromes Channelopathy Medical emergencies Medical genetics Long QT syndrome Ventricular fibrillation QT interval Genetic testing Cardiac dysrhythmia Health Medicine
232	Cystic Fibrosis Role Statement Role Statement for Accredited Practising Dietitians practising in the area of Cystic Fibrosis Developed by: Cystic Fibrosis Interest Group Date: June 2014 Add to Reading List Source URL: daa.asn.au Language: English - Date: 2014-07-28 23:23:29 Channelopathy Cystic fibrosis Pediatrics Dietitian Nutrition Physical therapy Cystic Fibrosis Trust Cystic Fibrosis Canada Medicine Health Health sciences
233	1216 Consultation Protocol to guide the assessment of testing for hereditary mutations in the Cystic Fibrosis conductance Transmembrane Regulator (CFTR) gene February 2014 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-19 23:54:21 Medical genetics Pancreas disorders Pediatrics Channelopathy Cystic fibrosis Sweat test Congenital absence of the vas deferens Point mutation Genetic testing Biology Health Medicine
234	Critical Care and Resuscitation Add to Reading List Source URL: www.cicm.org.au Language: English - Date: 2014-12-15 22:33:26 Biology Cardiac dysrhythmia Channelopathy Syndromes QT interval Long QT syndrome Eli Lilly and Company Electrocardiography Methadone Cardiac electrophysiology Physiology Chemistry
235	Malignant Hyperthermia Update Add to Reading List Source URL: www.rdasa.com.au Language: English - Date: 2013-04-28 03:01:57 Anesthesia Channelopathy Malignant hyperthermia Muscle relaxants Nitrobenzenes Dantrolene MH Desflurane Health Medicine Chemistry
236	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of ivacaftor (Kalydeco) for cystic fibrosis A stakeholder meeting was held on 31 July 2014 to discuss the Pharmaceutical Benefits Scheme (PBS) listing Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:51:53 Channelopathy Cystic fibrosis Pediatrics Ivacaftor Spirometry Pharmaceutical Benefits Scheme Clinical trial Health Medicine Pulmonology
237	Medical Intelligence Article The Myotonias and Susceptibility to Malignant Hyperthermia Jerome Parness, MD, PhD† Oliver Bandschapp, MD‡ Add to Reading List Source URL: www.rdasa.com.au Language: English* - Date: 2013-04-28 02:58:03 Biology Rare diseases Ion channels Myotonia Paramyotonia congenita Potassium-aggravated myotonia Malignant hyperthermia Nav1.4 Suxamethonium chloride Health Medicine Channelopathy
238	Cystic fibrosis Cystic fibrosis (CF) is an inherited disease for which there is currently no cure. CF can have many symptoms, affecting different parts of the body, but the lungs and digestion system are most severely af Add to Reading List Source URL: www.healthwise.org.hk Language: English - Date: 2010-08-19 23:50:09 Medicine Pancreas disorders Channelopathy Cystic fibrosis Cf Cystic Fibrosis Foundation Mucus Cough Meconium Health Biology Pediatrics
239	Qld CoA Stylised 2LS mono Add to Reading List Source URL: www.health.qld.gov.au Language: English - Date: 2014-06-24 19:47:59 Cystic fibrosis Pediatrics Medical prescription Nursing Health Medicine Channelopathy
240	ACCE REVIEW – Long-QT Syndrome (LQTS) Add to Reading List Source URL: www.genomics.health.wa.gov.au Language: English - Date: 2009-03-09 03:28:39 Channelopathy Medicine Rare diseases Long QT syndrome Jervell and Lange-Nielsen syndrome Genetic testing QT interval Short QT syndrome Health Cardiac dysrhythmia Syndromes

UPDATE